Stay updated on Efficacy of DaxibotulinumtoxinA in Glabellar Lines Clinical Trial
Sign up to get notified when there's something new on the Efficacy of DaxibotulinumtoxinA in Glabellar Lines Clinical Trial page.

Latest updates to the Efficacy of DaxibotulinumtoxinA in Glabellar Lines Clinical Trial page
- ChecktodayChange DetectedSite revision updated from v3.3.3 to v3.3.4; no changes to study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedAdded a consolidated Locations section listing study sites across Alabama, California, Colorado, Florida, Massachusetts, Michigan, New Jersey, New York, North Carolina, and Tennessee. Updated the page revision to v3.3.3 and removed the HHS Vulnerability Disclosure link and the previous v3.3.2 reference.SummaryDifference1%

- Check50 days agoChange DetectedThe Publications section wording was updated to indicate PubMed-sourced publications are automatically filled, and revision tags were updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check57 days agoChange DetectedRemoved the site-wide government funding/status notice. No study details, endpoints, or eligibility criteria are altered.SummaryDifference0.4%

- Check72 days agoChange DetectedNo additions or deletions were detected on the page; the study details and related information appear unchanged.SummaryDifference0.4%

- Check100 days agoChange DetectedUpgrade to v3.2.0 with a prominent operating-status notice and links to status pages; indicates continuing government funding fluctuations may affect site responsiveness.SummaryDifference5%

Stay in the know with updates to Efficacy of DaxibotulinumtoxinA in Glabellar Lines Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of DaxibotulinumtoxinA in Glabellar Lines Clinical Trial page.